Abstract
The prevalence of diabetes has been increasing at an alarming rate worldwide. Treatment of diabetes-related complications adds a huge financial burden on our health services, made worse in the current financial climate. The Eurodiale (European Study Group on Diabetes and the Lower Extremity) study was a prospective observational study conducted in 14 European centers in 2003 to 2004 and included data on characteristics of diabetic patients with foot ulcers, diagnostic and management procedures, health care organization, quality of life, and resource use. This was the first large multicenter study, included 1232 patients, and used an integrated approach for a multiorgan disease. The study has provided new insights into the intricacies involved in managing diabetic foot ulcers and how care can be improved. It has shown the differences in quality of care provided in different centers and also highlighted the need for more specific guidance related to diabetic foot disease.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
International Diabetes Federation (IDF): 2009. Diabetes Atlas. http://www.diabetesatlas.org/.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G. Apelqvist: the global burden of diabetic foot disease. Lancet. 2005;366:1719–24.
Dang CN, Boulton AJ. Changing perspectives in diabetic foot ulcer management. Int J Low Extrem Wounds. 2003;2:4–12.
Pinzur MS, Slovenkai MP, Trepman E, Shields NN. Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society. Foot Ankle Int. 2005;26(1):113–9.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.
• Vamos EP, Bottle A, Majeed A, Millett C. Trends in lower extremity amputations in people with and without diabetes in England, 1996–2005. Diabetes Research and Clinical Practice. 2010;87(2):275–82. The study showed that the number of both minor and major amputations in type 1 diabetes and nondiabetes-related amputations decreased during the study period but in patients with type 2 diabetes there was a significant increase, thereby highlighting the importance of diabetes prevention strategies and controlling risk factors for lower extremity amputations in people with diabetes.
Boulton AJ. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47:1343–53.
Beckert S, Witte M, Wicke C, et al. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care. 2006;29:988–92.
Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26:491–4.
Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001;18:133–8.
Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texaswound classification systems. Diabetes Care. 2001;24:84–8.
Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischaemia to risk of amputation. Diabetes Care. 1998;21:855–9.
Apelqvist J, Larsson J, Agardh CD. The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabet Med. 1990;7:590–4.
Frykberg RG. An evidence-based approach to diabetic foot infections. Am J Surg. 2003;186(5A):44S–54S.
Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233(6):485–91.
Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.
Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care. 2002;25:1835–9.
Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29:1784–7.
Prompers L, Huijberts M, Apelqvist J, et al. Optimal organization of health care in diabetic foot disease: introduction to the eurodiale study. Int J Low Extrem Wounds. 2007;6:11–7.
Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Int Med. 2002;252:225–32.
• Krishnan S, Nash F, Baker N, Rayman G. Reduction in diabetic amputations over 11 years in a defined UK population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care. 2008;31:99–101. Results showed a significant reduction in total and major amputation rates over an 11-year period following improvements in foot care services including multidisciplinary team work.
Habacher W, Rakovac I, Gorzer E, et al. A model to analyse costs and benefit of intensified diabetic foot care in Austria. J Eval Clin Pract. 2007;13:906–12.
Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Intern Med. 1994;235:463–71.
Ragnarson-Tennvall G, Apelqvist J, Eneroth M. The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. J Intern Med. 2000;248:397–405.
Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diab Metab. 2003;29:269–77.
Smith D, Cullen MJ, Nolan JJ. The cost of managing diabetic foot ulceration in an Irish hospital. Ir J Med Sci. 2004;173:89–92.
Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49:2634–41.
Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50:18–25.
Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008;25:700–7.
Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51:1826–34.
• Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia. 2008;51:747–55. The study showed that predictors of healing were different between patients with and without PAD, suggesting that diabetic foot ulcers with or without concomitant PAD should be defined as two separate entities.
van Battum P, Schaper N, Prompers L, et al. Minor amputation in diabetic foot disease; Friend or foe? Diabet Med. 2011;28:199–205.
Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998;15:508–14.
Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report criteria for including patients in research studies. Diab Metab Res Rev. 2004;20:S90–5.
Murabito JM, D’Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation. 1997;96:44–9.
American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–41.
Jude EB, Oyibo SO, Chalmers N, Boulton AJM. Peripheral arterial disease in diabetic and nondiabetic patients. Diabetes Care. 2001;24:1433–7.
Strandness DE, Priest RE, Gibbons GE. Combined clinical and pathological study of diabetic and nondiabetic peripheral arterial disease. Diabetes. 1964;13:366–72.
King TA, DePalma RG, Rhodes RS. Diabetes mellitus and atherosclerotic involvement of the profunda femoris artery. Surg Gynaecal Obstet. 1984;159:553–6.
Basil trial participants: Bypass versus angioplasty in severe ischaemia of the leg (BASIL).: multicentre randomised controlled trial. The Lancet 2005;366:1925–34.
Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between and 2003. Eur J Vasc Endovasc Surg. 1999;2005(29):620–7.
Nabuurs-Franssen MH, Sleegers R, Huijberts MS, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care. 2005;28:243–7.
Raymakers JT, Houben AJ, van der Heyden JJ. The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med. 2001;18:229–34.
Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27:2129–34.
• Sotto A, Richard JL, Combescure C, et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetes foot ulcers. Diabetologia 2010;53:2249–55. A total of 405 consecutive patients with suspected diabetic foot infection were included in the study. Implementation of Guidelines of the International Working Group on the Diabetic Foot for obtaining specimens for culture was cost saving and provided interesting quality indicators in the global management of diabetic foot infection.
Disclosure
Conflicts of interest: S. Akhtar: none; N. Schaper, J. Apelqvist and E. Jude: has received grant support from the European Commission to conduct the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akhtar, S., Schaper, N., Apelqvist, J. et al. A Review of the Eurodiale Studies: What Lessons for Diabetic Foot Care?. Curr Diab Rep 11, 302–309 (2011). https://doi.org/10.1007/s11892-011-0195-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-011-0195-x
Keywords
- Diabetes
- Foot ulcer
- Neuropathy
- Peripheral arterial disease
- Infection
- Lower extremity
- Osteomyelitis
- Ischemia
- Neuroischemia
- Referral
- Comorbidity
- Off-loading
- Antibiotics
- Revascularization
- Vascular
- Multicenter
- Prospective
- Outcome
- Healing
- Amputation
- Cost
- Resource utilization
- Health care organization
- Delivery of care
- Diabetic foot care